UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Triple-Negative Breast Cancer: A Review of Current Curative Intent Therapies

Current oncology (Toronto), 2022-07, Vol.29 (7), p.4768-4778

2022

Volltextzugriff (PDF)

Bone health after diagnosis of breast cancer

Canadian Medical Association journal (CMAJ), 2018-12, Vol.190 (49), p.E1452-E1452

2018

Volltextzugriff (PDF)

Research priorities in metastatic breast cancer: A James Lind Alliance Priority Setting Partnership

The breast journal, 2020-03, Vol.26 (3), p.488-493

2020

Volltextzugriff (PDF)

Economic analysis of osimertinib in previously untreated EGFR-mutant advanced non-small cell lung cancer in Canada

Lung cancer (Amsterdam, Netherlands), 2018-11, Vol.125, p.1-7

2018

Volltextzugriff (PDF)

Case report: Ultrahypofractionated palliative breast radiotherapy for a fungating invasive mammary carcinoma

Frontiers in oncology, 2023-06, Vol.13, p.1171444

2023

Volltextzugriff (PDF)

A Review of Trastuzumab Biosimilars in Early Breast Cancer and Real World Outcomes of Neoadjuvant MYL-1401O versus Reference Trastuzumab

Current oncology (Toronto), 2022-06, Vol.29 (6), p.4224-4234

2022

Volltextzugriff (PDF)

Drug development for breast, colorectal, and non–small cell lung cancers from 1979 to 2014

Cancer, 2017-12, Vol.123 (23), p.4672-4679

2017

Volltextzugriff (PDF)

A multi-centre study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of docetaxel-cyclophosphamide induced febrile neutropenia

Breast (Edinburgh), 2021-08, Vol.58, p.42-49

2021

Volltextzugriff (PDF)

Paraneoplastic acquired haemophilia A in extensive-stage small cell lung cancer (ES-SCLC) in the era of immunotherapy

BMJ case reports, 2021-01, Vol.14 (1), p.e236973

2021

Volltextzugriff (PDF)

The Canadian Breast Cancer Symposium 2023 Meeting Report

Current oncology (Toronto), 2024-04, Vol.31 (4), p.1774-1802

2024

Volltextzugriff (PDF)

Addressing the Rising Trend in Early-Age-Onset Cancers in Canada

Current oncology (Toronto), 2024-07, Vol.31 (7), p.4063-4078

2024

Volltextzugriff (PDF)

Selective Inhibition of Soluble TNF using XPro1595 Improves Hippocampal Pathology to Promote Improved Neurological Recovery Following Traumatic Brain Injury in Mice

CNS & neurological disorders drug targets, 2023-01, Vol.22 (9), p.1378-1390

2023

Volltextzugriff (PDF)

Impact of Value Frameworks on the Magnitude of Clinical Benefit: Evaluating a Decade of Randomized Trials for Systemic Therapy in Solid Malignancies

Current oncology (Toronto), 2021-11, Vol.28 (6), p.4894-4928

2021

Volltextzugriff (PDF)

Developing a clinical-pathologic model to predict genomic risk of recurrence in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative, node negative breast cancer

Cancer treatment and research communications, 2021, Vol.28, p.100401-100401, Article 100401

2021

Volltextzugriff (PDF)

Tumour thrombus of the inferior vena cava extending into the right atrium in the setting of colon cancer

BMJ case reports, 2017-02, Vol.2017, p.bcr2016218107

2017

Volltextzugriff (PDF)

Integrating biosimilars into oncology practice

Canadian oncology nursing journal, 2022-01, Vol.31 (4), p.2-6

2022

Volltextzugriff (PDF)

Perspectives actuelles sur l’intégration des médicaments biosimilaires à la pratique de l’oncologie au Canada

Canadian oncology nursing journal, 2022-01, Vol.31 (4), p.7-9

2022

Volltextzugriff (PDF)

Intégration des médicaments biosimilaires à la pratique de l’oncologie

Canadian oncology nursing journal, 2022-01, Vol.31 (4), p.2-6

2022

Volltextzugriff (PDF)

Current perspectives on integrating biosimilars in oncology practice in Canada

Canadian oncology nursing journal, 2022-01, Vol.31 (4), p.6-8

2022

Volltextzugriff (PDF)

Trastuzumab-dkst versus trastuzumab: Real-world pCR rates in patients with HER2+ breast cancer treated with neoadjuvant chemotherapy plus trastuzumab from Alberta, Canada

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e12569-e12569

2021

Volltextzugriff (PDF)

Local regional management of the axilla after positive sentinel node biopsy in breast cancer patients clinically downstaged with neoadjuvant therapy: A population-based, real-world analysis

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e12578-e12578

2022

Volltextzugriff (PDF)

Intégration des médicaments biosimilaires à la pratique de l'oncologie

Canadian oncology nursing journal, 2021-01, Vol.31 (4), p.2

2021

Volltextzugriff (PDF)

Perspectives actuelles sur l'intégration des médicaments biosimilaires à la pratique de l'oncologie au Canada

Canadian oncology nursing journal, 2021-01, Vol.31 (4), p.7

2021

Volltextzugriff (PDF)

Current perspectives on integrating biosimilars in oncology practice in Canada

Canadian oncology nursing journal, 2021-01, Vol.31 (4), p.6

2021

Volltextzugriff (PDF)

Integrating biosimilars into oncology practice

Canadian oncology nursing journal, 2021-01, Vol.31 (4), p.2

2021

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(95)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(59)
Life Sciences & Biomedicine
(49)
Humans
(37)
Female
(23)
Oncology
(16)
Male
(13)
Middle Aged
(13)
Adult
(12)
Hiv
(11)
Human Immunodeficiency Virus
(11)
Biological And Medical Sciences
(10)
Science & Technology - Other Topics
(10)
Multidisciplinary Sciences
(9)
Aged
(8)
Animals
(8)
Breast Cancer
(8)
Immunology
(8)
Medical Research
(8)
Cancer
(7)
Cancer Therapies
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Triple-Negative Breast Cancer: A Review of Current Curative Intent Therapies

Bone health after diagnosis of breast cancer

Research priorities in metastatic breast cancer: A James Lind Alliance Priority Setting Partnership

Economic analysis of osimertinib in previously untreated EGFR-mutant advanced non-small cell lung cancer in Canada

Case report: Ultrahypofractionated palliative breast radiotherapy for a fungating invasive mammary carcinoma

A Review of Trastuzumab Biosimilars in Early Breast Cancer and Real World Outcomes of Neoadjuvant MYL-1401O versus Reference Trastuzumab

Drug development for breast, colorectal, and non–small cell lung cancers from 1979 to 2014

A multi-centre study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of docetaxel-cyclophosphamide induced febrile neutropenia

Paraneoplastic acquired haemophilia A in extensive-stage small cell lung cancer (ES-SCLC) in the era of immunotherapy

The Canadian Breast Cancer Symposium 2023 Meeting Report

Addressing the Rising Trend in Early-Age-Onset Cancers in Canada

Selective Inhibition of Soluble TNF using XPro1595 Improves Hippocampal Pathology to Promote Improved Neurological Recovery Following Traumatic Brain Injury in Mice

Impact of Value Frameworks on the Magnitude of Clinical Benefit: Evaluating a Decade of Randomized Trials for Systemic Therapy in Solid Malignancies

Developing a clinical-pathologic model to predict genomic risk of recurrence in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative, node negative breast cancer

Tumour thrombus of the inferior vena cava extending into the right atrium in the setting of colon cancer

Integrating biosimilars into oncology practice

Perspectives actuelles sur l’intégration des médicaments biosimilaires à la pratique de l’oncologie au Canada

Intégration des médicaments biosimilaires à la pratique de l’oncologie

Current perspectives on integrating biosimilars in oncology practice in Canada

Trastuzumab-dkst versus trastuzumab: Real-world pCR rates in patients with HER2+ breast cancer treated with neoadjuvant chemotherapy plus trastuzumab from Alberta, Canada

Local regional management of the axilla after positive sentinel node biopsy in breast cancer patients clinically downstaged with neoadjuvant therapy: A population-based, real-world analysis

Intégration des médicaments biosimilaires à la pratique de l'oncologie

Perspectives actuelles sur l'intégration des médicaments biosimilaires à la pratique de l'oncologie au Canada

Current perspectives on integrating biosimilars in oncology practice in Canada

Integrating biosimilars into oncology practice

Suchergebnisse filtern